---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-007772"
form_type: "8-K"
ticker: "SEPN"
cik: "0001984086"
company_name: "Septerna, Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:15:39.825354+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Septerna appoints Mark A. Wilson as Chief Legal Officer, effective January 8, 2026

## Summary
- Mark A. Wilson joins from Nektar Therapeutics, where he was SVP and Chief Legal Officer.
- He has over 25 years of experience in IP, corporate legal, and strategic collaborations.
- Wilson will oversee legal, IP strategy, and governance for Septerna's GPCR drug discovery pipeline.
- He previously led global collaborations and patent strategy at Nektar.

## SEC filing metadata
- accession: 0001193125-26-007772
- form_type: 8-K
- ticker: SEPN
- cik: 0001984086
- company_name: Septerna, Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1984086/000119312526007772/0001193125-26-007772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1984086/000119312526007772/d40604d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-007772
- JSON: https://secwatch.observer/filing/0001193125-26-007772.json
- Plain text: https://secwatch.observer/filing/0001193125-26-007772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.